Status:
COMPLETED
CPAP Efficacy in Post-COVID-19 Patients With Sleep Apnea
Lead Sponsor:
Venkatesh Krishnamurthy
Collaborating Sponsors:
Breathe Pennsylvania
Conditions:
COVID-19
Sleep Apnea
Eligibility:
All Genders
18-75 years
Brief Summary
This is a prospective, observational study evaluating the relationship between severity of sleep apnea with severity of cognitive fog and if treatment of sleep apnea with CPAP improves cognitive fog i...
Detailed Description
The overarching goal of this proposal is to evaluate the extent to which OSA may be a common, treatable comorbidity in post-COVID patients suffering from cognitive fog and whether addressing the sleep...
Eligibility Criteria
Inclusion
- Patients more than 18 years of age.
- Diagnosed with COVID and continues to have persistent symptoms beyond 4 weeks.
- Diagnosed with sleep apnea based on a home sleep study
Exclusion
- Patients with Narcolepsy or other acute Primary sleep problems.
- Cognitive impairment secondary to a neurodegenerative disorders and dementia.
- Acute exacerbation of psychiatric illness including severe depression, schizophrenia or bipolar disorder in the past 30 days.
- Serious medical or neurological illness or infection requiring hospitalization or unable to function in the past 30 days.
- Any medications that were started or change in dosage of the following medication in the past 30 days including: corticosteroids, stimulants, benzodiazepines/non benzodiazepine receptor agonists, antidepressants, antipsychotics or other medications which alter cognition.
- Patients who are on any active treatment for sleep apnea including CPAP, dental device or implant for two weeks before enrolling into the study.
Key Trial Info
Start Date :
January 4 2024
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2024
Estimated Enrollment :
22 Patients enrolled
Trial Details
Trial ID
NCT06052514
Start Date
January 4 2024
End Date
December 31 2024
Last Update
February 7 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Pittsburgh
Pittsburgh, Pennsylvania, United States, 15260